Robotic knee surgery platform developer OmniLife Science said today it began testing on its OmniBotics active spacer robotic tissue balancing device at 3 US sites after having won FDA 510(k) clearance in September. The Raynham, Mass.-based company said its OmniBotics active spacer is designed to allow surgeons performing total knee surgeries to quantitatively manage the…